首页 / 院系成果 / 成果详情页

Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography 期刊论文

编号：

920B2DAA6C20612373D3E9DE3EDE8D90
作者：

He, Ruiling#^[1,2]Liu, Chuan#^[3,13]Grgurevic, Ivica#^[4,5]Guo, Ying#^[6]Xu, Huixiong(徐辉雄)#^[7]Liu, Jiacheng(刘嘉城)#^[8]Liu, Yunfang^[6];Wang, Xiaoyan^[6];Shi, Hongmei^[9];Madir, Anita^[10];Podrug, Kristian^[11];Zhu, Yuli(朱宇莉)^[7]Hua, Yongli^[6];Wang, Kun^[6];Wen, Jing^[6];Su, Meiqin^[9];Zhang, Qun(张群)^[12]Li, Jie(李婕)*^[8]Qi, Xiaolong(祁小龙)*^[2]
语种：

英文
期刊：

HEPATOLOGY INTERNATIONAL ISSN：1936-0533 2024 年 18 卷 3 期 (1020 - 1028) ; JUN
收录：
关键词：

Baveno VII criteria Clinically significant portal hypertension Two-dimensional shear wave elastography Liver stiffness measurement Spleen stiffness measurement
摘要：

Background The Baveno VII consensus proposed criteria for the non-invasively diagnosis of clinically significant portal hypertension (CSPH) in patients with compensated advanced chronic liver disease (cACLD). The performance of Baveno VII criteria for assessing CSPH by two-dimensional shear wave elastography (2D-SWE) had not been well validated. We aimed to validate the performance of Baveno VII criteria for rule-in and rule-out CSPH by 2D-SWE. Method This is an international multicenter study including cACLD patients from China and Croatia with paired liver stiffness measurement (LSM), spleen stiffness measurement (SSM) by 2D-SWE, and hepatic venous pressure gradient (HVPG) were included. CSPH was defined as HVPG >= 10 mmHg. Result A total of 146 patients with cACLD were enrolled, and finally 118 patients were included in the analysis. Among them, CSPH was documented in 79 (66.9%) patients. Applying the Baveno VII criteria for rule-out CSPH by 2D-SWE, [LSM <= 15 kPa and platelet count >= 150 x 109/L] OR SSM < 21 kPa, could exclude CSPH with sensitivity > 90% (93.5 or 98.7%) but negative predictive value < 90% (74.1 or 85.7%). Using the Baveno VII criteria for rule-in CSPH by 2D-SWE, LSM >= 25 kPa OR SSM >= 50 kPa, could diagnose CSPH with 100% specificity and 100% positive predictive values. Conclusion Baveno VII criteria by 2D-SWE showed a good diagnostic performance for ruling in but not for ruling out CSPH, which might become an emerging non-invasive elastography tool to select the patients who needed non-selective beta blocker therapy.
推荐引用方式
GB/T 7714：

He Ruiling,Liu Chuan,Grgurevic Ivica, et al. Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography [J].HEPATOLOGY INTERNATIONAL,2024,18(3):1020-1028.
APA：

He Ruiling,Liu Chuan,Grgurevic Ivica,Guo Ying,&Qi Xiaolong.(2024).Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography .HEPATOLOGY INTERNATIONAL,18(3):1020-1028.
MLA：

He Ruiling, et al. "Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography" .HEPATOLOGY INTERNATIONAL 18,3(2024):1020-1028.
入库时间：

6/2/2024 8:17:15 PM
更新时间：

6/2/2024 8:17:15 PM
条目包含文件：

文件类型： , 文件大小：

正在加载全文

未找到全文

浏览次数：94  下载次数：0

分享到：

浏览次数：94

下载次数：0

打印次数：0